[Retracted] Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma

Figure 7

Molecular docking models of lenvatinib binding to the six predicted protein targets. (a-f) 3D interaction diagrams of lenvatinib in the active sites of the proteins encoded by ALB (a), CCND1 (b), ESR1 (c), AR (d), CCNA2 (e), and AURKA (f), respectively.

(a)

(b)

(c)

(d)

(e)

(f)